Methylation of 6-mercaptopurine and 6-thioguanine by thiopurine S-methyltransferase -: A comparison of activity in red blood cell samples of 199 blood donors

被引:25
作者
Kröplin, T [1 ]
Iven, H [1 ]
机构
[1] Med Univ Lubeck, Dept Expt & Clin Pharmacol & Toxicol, D-23538 Lubeck, Germany
关键词
6-thioguanine; 6-mercaptopurine; thiopurine S-methyltransferase;
D O I
10.1007/s002280000137
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To compare 6-mercaptopurine (6-MP) and 6-thioguanine (6-TG) as substrates for the methylation reaction catalysed by the enzyme thiopurine S-methyltransferase (TPMT). Methods: TPMT activity in haemolysed red blood cells of healthy blood donors was determined twice, using the same experimental setting and equal molar concentrations of 6-TG and 6-MP as substrates. After extraction, the reaction products 6-methyl-TG and 6-methyl-MP were quantified using specific high-performance liquid chromatography procedures. Results: The medians of the TPMT activities from 199 blood donors were 54.4 nmol 6-MTG g(-1) Hb h(-1) when measured with 6-TG as the substrate and 35.8 nmol 6-MMP g(-1) Hb h(-1) when measured with 6-MP. The correlation coefficient for the 199 pairs of values was 0.8695. On average, TPMT activity was 34% lower with 6-MP as substrate than with 6-TG as substrate.
引用
收藏
页码:343 / 345
页数:3
相关论文
共 10 条
[1]  
BACH JF, 1985, MODE ACTION IMMUNOSU, P105
[2]  
DEABREU RA, 1994, ADV EXP MED BIOL, V370, P195
[3]   PURINE SUBSTRATES FOR HUMAN THIOPURINE METHYLTRANSFERASE [J].
DEININGER, M ;
SZUMLANSKI, CL ;
OTTERNESS, DM ;
VANLOON, J ;
FERBER, W ;
WEINSHILBOUM, RM .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (11) :2135-2138
[4]   Inhibition of thiopurine S-methyltransferase activity by impurities in commercially available substrates:: a factor for differing results of TPMT measurements [J].
Kröplin, T ;
Fischer, C ;
Iven, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (04) :285-291
[5]   Thiopurine S-methyltransferase activity in human erythrocytes:: a new HPLC method using 6-thioguanine as substrate [J].
Kröplin, T ;
Weyer, N ;
Gutsche, S ;
Iven, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) :265-271
[6]  
KRYNETSKI EY, 1995, MOL PHARMACOL, V47, P1141
[7]   Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism [J].
Lennard, L ;
Lilleyman, JS .
THERAPEUTIC DRUG MONITORING, 1996, 18 (04) :328-334
[8]   IS 6-THIOGUANINE MORE APPROPRIATE THAN 6-MERCAPTOPURINE FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
LENNARD, L ;
DAVIES, HA ;
LILLEYMAN, JS .
BRITISH JOURNAL OF CANCER, 1993, 68 (01) :186-190
[9]   GENETIC-VARIATION IN RESPONSE TO 6-MERCAPTOPURINE FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
LENNARD, L ;
LILLEYMAN, JS ;
VANLOON, J ;
WEINSHILBOUM, RM .
LANCET, 1990, 336 (8709) :225-229
[10]   HUMAN ERYTHROCYTE THIOPURINE METHYLTRANSFERASE - RADIOCHEMICAL MICROASSAY AND BIOCHEMICAL PROPERTIES [J].
WEINSHILBOUM, RM ;
RAYMOND, FA ;
PAZMINO, PA .
CLINICA CHIMICA ACTA, 1978, 85 (03) :323-333